Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
ADAR1 affects HCV infection by modulating innate immune response.
Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial.
Real World Patient-reported Outcomes in HIV-infected Adults Switching to EVIPLERA®, Because of a Previous Intolerance to cART. PRO-STR Study.
Antigen Production After Latency Reversal and Expression of Inhibitory Receptors in CD8+ T Cells Limit the Killing of HIV-1 Reactivated Cells.
High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs.
Recurrent coronary disease in HIV-infected patients: role of drug-drug interactions.
Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir.
Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4 + T-cell immune recovery
Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death.